Glassman Wealth Services Astrazeneca PLC Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $7,860 - $8,798	127 Added 7.77%	1,762 $118,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $22,438 - $24,808	346 Added 26.84%	1,635 $110,000
Q2 2023 Aug 08, 2023	SELL	$69.91 - $75.81 $139 - $151	-2 Reduced 0.15%	1,289 $92,000
Q1 2023 May 04, 2023	BUY	$63.15 - $71.6 $4,104 - $4,654	65 Added 5.3%	1,291 $89,000
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $1,246 - $1,620	23 Added 1.91%	1,226 $83,000
Q3 2022 Nov 09, 2022	BUY	$53.02 - $135.75 $2,385 - $6,108	45 Added 3.89%	1,203 $66,000
Q2 2022 Aug 04, 2022	SELL	$59.26 - $71.14 $11,911 - $14,299	-201 Reduced 14.79%	1,158 $77,000
Q1 2022 Aug 23, 2022	BUY	$55.72 - $67.12 $10,921 - $13,155	196 Added 16.85%	1,359 $90,000
Q1 2022 Apr 14, 2022	BUY	$55.72 - $67.12 $6,909 - $8,322	124 Added 11.93%	1,163 $77,000
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $4,159 - $4,914	77 Added 8.0%	1,039 $61,000
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $16,668 - $18,237	300 Added 45.32%	962 $58,000
Q2 2021 Aug 04, 2021	BUY	$48.42 - $60.18 $5,810 - $7,221	120 Added 22.14%	662 $40,000
Q1 2021 May 05, 2021	SELL	$47.16 - $54.44 $63,996 - $73,875	-1,357 Reduced 71.46%	542 $27,000
Q4 2020 Feb 04, 2021	BUY	$48.52 - $58.02 $26,588 - $31,794	548 Added 40.56%	1,899 $95,000
Q3 2020 Nov 09, 2020	BUY	$53.07 - $61.1 $69,309 - $79,796	1,306 Added 2902.22%	1,351 $74,000
Q1 2020 May 12, 2020	BUY	$37.79 - $51.33 $529 - $718	14 Added 45.16%	45 $2,000
Q4 2019 Feb 07, 2020	BUY	$42.46 - $50.46 $1,316 - $1,564	31 New	31 $2,000
Q4 2018 Feb 06, 2019	SELL	$36.86 - $41.49 $8,993 - $10,123	-244 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $1,911 - $2,184	55 Added 29.1%	244 $10,000
Q4 2017 Feb 06, 2018	BUY	$32.09 - $34.78 $6,065 - $6,573	189	189 $7,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account